HUTCHMED (China) Limited - ADR

XNAS: HCM

Download real time

15.09 0.10 (0.67%)

31.16% Fall from 52W High

60,721 XNAS Volume

XNAS 24 Mar, 2025 5:30 PM (EDT)

2,580

Market Cap

High in industry

0.6

Beta 1Year

Very Low volatility

Insider Trading disclosures for HUTCHMED (China) Limited - ADR

The latest disclosure was made by Weiguo Su in HUTCHMED (China) Limited - ADR where a trade of 19,913 Ords 0.10p done was reported to US exchanges on March 13, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Weiguo Su	Executive Director,Chief Executive Officer and Chief Scientific Officer		13 Mar 2025	19,913	6,423,088 (0%)	0%		0	Ords 0.10p
Graeme Allan Jack	Non-Executive Director		20 Oct 2024	9,690	96,385 (0%)	0%		0	Ords 0.10p
Dan Eldar	Non-Executive Director,Chairman		20 Oct 2024	9,690	160,350 (0%)	0%		0	Ords 0.10p
Paul Rutherford Carter	Non-Executive Director,Senior Independent Director		20 Oct 2024	8,235	117,160 (0%)	0%		0	Ords 0.10p
Shu Kam Tony Mok	Non-Executive Director		20 Oct 2024	9,690	146,395 (0%)	0%		0	Ords 0.10p
Johnny Cheng Chig Fung	Executive Director,Chief Financial Officer		04 Mar 2024	227,115	1,680,095 (0%)	0%		0	Ords 0.10p
Weiguo Su	Executive Director,Chief Executive Officer		04 Mar 2024	1,403,175	6,403,175 (0%)	0%		0	Ords 0.10p

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades disclosures

Screeners based on Insider Trading and SAST parameters